Evidence Synthesis
AstraZen (ASTRAZEN) has posted a 36.83% gross margin, accelerating from 6.4% in the previous quarter.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 7 Sept 2026, 00:21
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
AstraZen (ASTRAZEN) has posted a 36.83% gross margin, accelerating from 6.4% in the previous quarter.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 36.83 % | 6.4 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 6.4 % | 6.97 | ▼ |
| REVENUE_GROWTH_YOY | 29.7 % | -32.1 | ▲ |
| EPS_ACTUAL | 10.68 INR | 3.83 | ▲ |
| EPS_SURPRISE_PERCENT | 0.133 % | -0.538 | ▲ |
| PRICE_CHANGE_PERCENT | 0.137 % | — | - |
| DAILY_VOLUME | 6,489 shares | 11,005 | ▼ |
| CLOSE_PRICE | 6,950 INR | 6,940.5 | ▲ |